We're raising our price target on Eli Lilly as the obesity-drug boom rolls on

The Quick Take
The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to CNBC Top News.
Related
Markets
Monolithic Power Systems names new CFO and CAO
Markets
*HOT* Inflatable Stand Up Paddle Board only $75.99 shipped!
These Inflatable Paddle Boards are a great deal! Amazon has this FunWater Inflatable Stand Up Paddle Board for only $75.99 shipped when you use promo code…
Markets
First Solar GAAP EPS of $5.30 beats by $0.66, revenue of $1.23B misses by $60M
Markets
